跳至主要内容
临床试验/CTRI/2023/09/057995
CTRI/2023/09/057995尚未招募4 期

Comparison of effectivity and safety of Olanzapine and Mirtazapine on cancer associated anorexia and cachexia in advanced oral cavity cancer patients: A prospective, comparative, interventional study - nil

nil0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.Age 18 years and above
  • 2.Registered in palliative care centre
  • 3.Suffering from an histologically diagnosed advanced oral cavity cancer (Cancer with Mets)
  • 4.Patients with a weight loss >5% of body weight over past 6 month OR loss of 2-5% of body weight over past 6 month plus body mass index (BMI) <20
  • 5.Loss of appetite score <14
  • 6.Patient giving written informed consent for this study
  • 7.Who’ll give written informed consent to be included in study

排除标准

  • 1.Pregnant and lactating female
  • 2.Known history of hypersensitive to study drugs
  • 3.Severe renal impairment,
  • 4.Severe liver impairment,
  • 5.Significant disorder of bone marrow
  • 6.Cardiac conduction defect.
  • 7.Patient taking Antipsychotic, sedative- psychotropic drug, Atropine and its substitute.
  • 8.Non co-operative patient

研究者

发起方
nil

相似试验